Table 1.
Quality measure definitions
| Quality measure | Denominator (determined day prior to visit) | Numerator (determined 30 days after visit) |
| Coronary artery disease | ||
| Antiplatelet medication | No allergy or contraindication to antiplatelet medications | Antiplatelet agent on medication list or new contraindication in allergies or problem list |
| β Blocker | Patient with myocardial infarction, angina, or congestive heart failure, and no allergies or contraindication to β blockers | β Blocker on medication list or a new contraindication in allergies or problem list |
| Coronary artery disease or diabetes | ||
| Cholesterol testing | All patients | LDL test result in clinical data repository or health maintenance section within the previous 13 months |
| Cholesterol control | All patients | An LDL test result <100 mg/dl prior to visit, after visit, or subsequent intensification of antihyperlipidemic therapy on medication list |
| Blood pressure documentation | All patients | Blood pressure result in coded vital signs |
| Blood pressure control | All patients | Blood pressure in coded field <140/90 mm Hg or <130/80 mm Hg for patients with diabetes or renal disease as of visit or subsequent intensification of antihypertensive therapy on medication list |
| Tobacco use documentation | All patients | Tobacco use status in problem list or health maintenance section |
| Body mass index | All patients | Weight within 13 months and height within 5 years if patient >23 years old (otherwise within 13 months) in vital signs |
| Influenza vaccine | All patients visiting between October 1 and April 31 | Receipt of influenza vaccine as noted in immunization section of chart |
| Diabetes | ||
| ACE-I/ARB | No allergy or contraindication to either ACE-I or ARB | ACE-I or ARB on medication list or a new contraindication documented |
| HbA1c testing | All patients | HbA1c test in clinical data repository or health maintenance section within the previous 13 months |
| Glucose control | All patients | HbA1c result <7% as of visit or subsequent intensification of antihyperglycemic therapy on medication list |
| Foot exam | All patients | Foot exam in health maintenance section within the previous 13 months |
| Eye exam | All patients | Eye exam in health maintenance section within the previous 13 months |
| Microalbuminuria testing | All patients | Urine microalbumin testing in clinical data repository or health maintenance section within the previous 13 months |
ACE-I, ACE inhibitor; ARB, angiotensin receptor blocker; LDL, low density lipoprotein.